HO/02/02 20µg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HO/02/02 20µg, covering 2013-08-15 to 2013-08-15. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of HO/02/02 20µg vs. SoC (Aloe Vera) to Reduce Radiation Dermatitis [EARLY_Phase 1]